HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaki Sato Selected Research

Gemcitabine

6/2021Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signaling.
8/2011ATP assay-guided chemosensitivity testing for gemcitabine with biopsy specimens obtained from unresectable pancreatic cancer using endoscopic ultrasonography-guided fine-needle aspiration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaki Sato Research Topics

Disease

11Neoplasms (Cancer)
12/2023 - 10/2006
4Cataract (Cataracts)
12/2019 - 06/2005
4Pain (Aches)
04/2016 - 11/2009
3Infections
01/2024 - 01/2008
3Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 06/2010
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 03/2020
3Stomach Neoplasms (Stomach Cancer)
12/2020 - 01/2014
3Thrombosis (Thrombus)
12/2009 - 06/2002
3Pneumonia (Pneumonitis)
07/2009 - 08/2006
2Squamous Cell Carcinoma of Head and Neck
12/2023 - 10/2006
2Heart Failure
03/2023 - 12/2022
2Rheumatoid Arthritis
05/2022 - 05/2012
2Neoplasm Metastasis (Metastasis)
12/2020 - 10/2006
2Edema (Dropsy)
10/2020 - 03/2019
2Paralysis (Palsy)
08/2016 - 05/2003
2Leukemia
01/2015 - 06/2010
2Ulcer
12/2014 - 11/2007
2Hemorrhage
12/2014 - 01/2014
2Interstitial Lung Diseases (Interstitial Lung Disease)
05/2012 - 01/2007
2Lymphoma (Lymphomas)
01/2009 - 07/2005
2Rupture
06/2005 - 07/2004
1Major Depressive Disorder (Major Depressive Disorders)
12/2023
1Exanthema (Rash)
11/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1Carcinogenesis
11/2022
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2022
1Temporomandibular Joint Disorders (Temporomandibular Joint Disorder)
12/2021
1Double Outlet Right Ventricle
05/2021
1Colonic Neoplasms (Colon Cancer)
12/2020
1Inflammation (Inflammations)
10/2020
1Cardiomyopathies (Cardiomyopathy)
01/2020
1Myocardial Infarction
01/2020
1Disease Progression
01/2019
1Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency)
01/2019
1Adenocarcinoma
01/2019
1Renal Cell Carcinoma (Grawitz Tumor)
01/2018

Drug/Important Bio-Agent (IBA)

4SteroidsIBA
01/2017 - 07/2004
3Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2019
3Anti-Bacterial Agents (Antibiotics)IBA
07/2009 - 06/2007
2ErbB Receptors (EGF Receptor)IBA
11/2023 - 10/2006
2CholesterolIBA
01/2023 - 01/2019
2Methotrexate (Mexate)FDA LinkGeneric
05/2022 - 05/2012
2Proteins (Proteins, Gene)FDA Link
06/2021 - 03/2019
2GemcitabineFDA Link
06/2021 - 08/2011
2MineralsIBA
10/2020 - 03/2019
2Indicators and Reagents (Reagents)IBA
03/2020 - 01/2019
2Anesthetics (Anesthetic Agents)IBA
04/2016 - 10/2008
2Adenosine Triphosphate (ATP)IBA
04/2015 - 08/2011
2Etoposide (VP 16)FDA LinkGeneric
01/2015 - 02/2013
2C-Reactive ProteinIBA
07/2012 - 01/2008
2Immunoglobulin M (IgM)IBA
11/2009 - 12/2007
2Hyaluronic Acid (Hyaluronan)IBA
11/2008 - 02/2008
2AntigensIBA
01/2008 - 10/2006
2Capsules (Microcapsules)IBA
06/2005 - 07/2004
2SuspensionsIBA
06/2005 - 07/2004
2Hydrocortisone (Cortisol)FDA LinkGeneric
06/2005 - 07/2004
2Cortodoxone (11 Deoxycortisol)IBA
06/2005 - 07/2004
1MAP-kinase-activated kinase 2IBA
12/2023
1EscitalopramFDA Link
12/2023
1Fatty Acid-Binding ProteinsIBA
03/2023
1HDL LipoproteinsIBA
01/2023
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2023
1LipidsIBA
01/2023
1ApolipoproteinsIBA
01/2023
1HDL CholesterolIBA
01/2023
1phosphatidylethanolamineIBA
01/2023
1Glucosylceramides (Glucocerebrosides)IBA
11/2022
1Biosimilar PharmaceuticalsIBA
05/2022
1Adalimumab (Humira)FDA Link
05/2022
1Proprotein Convertase 9IBA
01/2022
1Leucine (L-Leucine)FDA Link
06/2021
1CateninsIBA
06/2021
1CaspasesIBA
06/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2020
1S-1 plus cisplatinIBA
12/2020
1Oxygen (Dioxygen)IBA
10/2020
1Chelating AgentsIBA
01/2020
1DeferasiroxFDA Link
01/2020
1IronIBA
01/2020
1Lipoproteins (Lipoprotein)IBA
01/2019
1Lipoprotein-XIBA
01/2019
1Filipin (Filipin III)IBA
01/2019
1Salmeterol Xinafoate (Serevent)FDA Link
01/2018

Therapy/Procedure

10Therapeutics
12/2020 - 01/2008
4Drug Therapy (Chemotherapy)
06/2010 - 10/2006
3Stents
01/2021 - 03/2020
2Aftercare (After-Treatment)
12/2022 - 09/2005
2Laser In Situ Keratomileusis (LASIK)
03/2017 - 04/2004
2Anesthesia
04/2016 - 10/2008
2Punctures
02/2014 - 06/2007
2Nerve Block (Nerve Blocks)
10/2013 - 11/2009
2Phacoemulsification
11/2008 - 02/2008
2Oxygenators
01/2007 - 06/2002
2Vitrectomy
06/2005 - 07/2004
1Secondary Prevention
12/2023
1Activities of Daily Living (ADL)
05/2022
1Diskectomy (Discectomy)
12/2021
1Catheters
05/2021
1Adjuvant Chemotherapy
10/2020
1Multifocal Intraocular Lenses
12/2019